Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System
Growth Stock Investing and Trading for Stock Market Investors - Since 1996 | MyStockScreen.com | Home | Join Now | Member Login | Refer a Friend | Contact Us
Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Market Direction and More...
HI-EPSRS
Screener
My Watch
List
Market
Direction
Industry
Map
My
Account
Help Logout
Symbol:
Enter Symbols Separated By Spaces.
Download All Symbols To Text/CSV

Top Picks Watch List
Dist.Days: SPY:4 DOW:4 QQQ:2

GSA Live Portfolio:
FNSR PRO
2022-11-08: We have a signal to move out of CASH and into FBSOX....Read more

HI-EPSRS Database Search Results   

Search Results      Stocks 1 through 5 of 5 shown        Download Search Results Symbols To Text/CSV

ICU Medical Inc (ICUI)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

2/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

21%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
70.16
Acc Dist
1.56
Disc
197.78%
Avg Vol
103,500
Liquidity
0.55%
Below High
0.25%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-101%  -299%
EPS Growth
-18%
Sls Growth
5%
Proj Growth
15.8%
Anal. Rank
3.50
Shares
20.1M
Instit
86%
3-Month Trends of Key Indicators:
Looks Like a Winner?
ICUI looks better than most Top Picks Winners* in 2 out of 10 key factors.
Accum/Dist: 1.56 (median winner: 1.53)
Above 40wkMA: 27% (median winner: 35%)
Instit. Ownership: 86% (median winner: 63%)
Liquidity: 0.55% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 70.16 (winner: 75.66)
Sales Growth: 5% (median winner: 28%)
Below 52wk High: 0.25% (winner: 3.30%)
Relative Strength: 91 (winner: 96)
Avg Qrtly EPS: -200% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • Edited Transcript of ICUI earnings conference call or presentation 9-Nov-17 9:30pm GMT Fri, 24 Nov 2017 07:57:42 +0000
    Q3 2017 ICU Medical Inc Earnings Call
  • See what the IHS Markit Score report has to say about ICU Medical Inc. Thu, 23 Nov 2017 13:07:03 +0000
    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
  • ICU Medical, Inc. – Value Analysis (NASDAQ:ICUI) : November 14, 2017 Tue, 14 Nov 2017 20:29:27 +0000
    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ICU Medical, Inc. a score of 63. Our analysis is based on comparing ICU Medical, Inc. with the following peers – Merit Medical Systems, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., Insulet Corporation, Delcath Systems, Inc., Teleflex Incorporated, Becton, Dickinson and Company and Baxter International Inc. (MMSI-US, EW-US, ... Read more (Read more...)
  • This Simple, Lifesaving Liquid Is Suddenly in Short Supply Tue, 14 Nov 2017 11:00:15 +0000
    A dangerous shortage of saline bags, years in the making, has gotten worse after Hurricane Maria knocked out factories in Puerto Rico.
  • ICU Medical (ICUI) in Focus: Stock Moves 10.2% Higher Mon, 13 Nov 2017 13:40:01 +0000
    ICU Medical (ICUI) saw its shares rise over 10% on the day.
  • ICU Medical, Inc. breached its 50 day moving average in a Bullish Manner : ICUI-US : November 13, 2017 Mon, 13 Nov 2017 12:25:18 +0000
    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ICU Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
  • ETFs with exposure to ICU Medical, Inc. : November 10, 2017 Fri, 10 Nov 2017 17:36:07 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ICU Medical, Inc. Here are 5 ETFs with the largest exposure to ICUI-US. Comparing the performance and risk of ICU Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
  • ICU Medical posts 3Q profit Thu, 09 Nov 2017 23:27:52 +0000
    The San Clemente, California-based company said it had profit of 1 cent per share. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.12 per share. The medical device maker ...
  • ICU Medical, Inc. Announces Third Quarter 2017 Results Thu, 09 Nov 2017 21:05:00 +0000
    SAN CLEMENTE, Calif., Nov. 09, 2017-- ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced ...
  • ICU Medical, Inc. to Host Earnings Call Thu, 09 Nov 2017 17:00:00 +0000
    NEW YORK, NY / ACCESSWIRE / November 9, 2017 / ICU Medical, Inc. (NASDAQ: ICUI ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time. ...

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
ICUI EPS/Sales Growth ICUI vs. Peers

Spectrum Pharmaceuticals Inc (SPPI)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.2/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

5%
Group
Action

Group Action Ranking

59
"Must Have"/Timing Factors
GSA
68.37
Acc Dist
1.62
Disc
0.00%
Avg Vol
1,970,700
Liquidity
2.01%
Below High
9.66%
Group Action
59
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
0%  28%
EPS Growth
0%
Sls Growth
-14%
Proj Growth
N/A %
Anal. Rank
5.00
Shares
100.7M
Instit
72%
3-Month Trends of Key Indicators:
Looks Like a Winner?
SPPI looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 1.62 (median winner: 1.53)
Above 40wkMA: 104% (median winner: 35%)
Instit. Ownership: 72% (median winner: 63%)
Liquidity: 2.01% (median winner: 1.18%)
Group Action: 59 (median winner: 20)
GSA Rank: 68.37 (winner: 75.66)
Sales Growth: -14% (median winner: 28%)
Below 52wk High: 9.66% (winner: 3.30%)
Relative Strength: 99 (winner: 96)
Avg Qrtly EPS: 14% (median winner: 68%)
Industry Group: 59. Drug Manufacturers - Major

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Spectrum Pharmaceuticals - a pharmaceutical company focused on oncology drugs and unmet medical needs

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
SPPI EPS/Sales Growth SPPI vs. Peers

Ebix Inc (EBIX)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.9/1.0
Sales
Consistency

Sales Consistency Ranking

0.9/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

3/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

4%
Group
Action

Group Action Ranking

11
"Must Have"/Timing Factors
GSA
67.22
Acc Dist
3.17
Disc
148.70%
Avg Vol
148,400
Liquidity
0.38%
Below High
0.13%
Group Action
11
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
3%  7%
EPS Growth
20%
Sls Growth
11%
Proj Growth
10%
Anal. Rank
5.00
Shares
31.5M
Instit
64%
3-Month Trends of Key Indicators:
Looks Like a Winner?
EBIX looks better than most Top Picks Winners* in 3 out of 10 key factors.
Accum/Dist: 3.17 (median winner: 1.53)
Above 40wkMA: 26% (median winner: 35%)
Instit. Ownership: 64% (median winner: 63%)
Liquidity: 0.38% (median winner: 1.18%)
Group Action: 11 (median winner: 20)
GSA Rank: 67.22 (winner: 75.66)
Sales Growth: 11% (median winner: 28%)
Below 52wk High: 0.13% (winner: 3.30%)
Relative Strength: 90 (winner: 96)
Avg Qrtly EPS: 5% (median winner: 68%)
Industry Group: 11. Business Software & Services

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Ebix Inc is a leading supplier of On-Demand insurance software solutions & E-commerce services to the insurance industry in Offshore & Custom software development.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
EBIX EPS/Sales Growth EBIX vs. Peers

Quaker Chemical Corp (KWR)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

3/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

5%
Group
Action

Group Action Ranking

20
"Must Have"/Timing Factors
GSA
59.47
Acc Dist
1.74
Disc
193.91%
Avg Vol
61,900
Liquidity
0.45%
Below High
2.61%
Group Action
20
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-31%  -20%
EPS Growth
-2%
Sls Growth
1%
Proj Growth
11%
Anal. Rank
2.50
Shares
13.3M
Instit
86%
3-Month Trends of Key Indicators:
Looks Like a Winner?
KWR looks better than most Top Picks Winners* in 3 out of 10 key factors.
Accum/Dist: 1.74 (median winner: 1.53)
Above 40wkMA: 13% (median winner: 35%)
Instit. Ownership: 86% (median winner: 63%)
Liquidity: 0.45% (median winner: 1.18%)
Group Action: 20 (median winner: 20)
GSA Rank: 59.47 (winner: 75.66)
Sales Growth: 1% (median winner: 28%)
Below 52wk High: 2.61% (winner: 3.30%)
Relative Strength: 83 (winner: 96)
Avg Qrtly EPS: -26% (median winner: 68%)
Industry Group: 20. Specialty Chemicals

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
KWR EPS/Sales Growth KWR vs. Peers

iShares MSCI Canada Index (EWC)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.0/1.0
Sales
Consistency

Sales Consistency Ranking

0.0/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

4/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

2%
Group
Action

Group Action Ranking

9
"Must Have"/Timing Factors
GSA
0.00
Acc Dist
1.40
Disc
0.00%
Avg Vol
1,955,400
Liquidity
0.00%
Below High
0.14%
Group Action
9
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
N/A%  N/A%
EPS Growth
0%
Sls Growth
0%
Proj Growth
N/A %
Anal. Rank
0.00
Shares
0M
Instit
0%
3-Month Trends of Key Indicators:
Looks Like a Winner?
EWC looks better than most Top Picks Winners* in 4 out of 10 key factors.
Accum/Dist: 1.40 (median winner: 1.53)
Above 40wkMA: 7% (median winner: 35%)
Instit. Ownership: 0% (median winner: 63%)
Liquidity: 0.00% (median winner: 1.18%)
Group Action: 9 (median winner: 20)
GSA Rank: 0.00 (winner: 75.66)
Sales Growth: 0% (median winner: 28%)
Below 52wk High: 0.14% (winner: 3.30%)
Relative Strength: 76 (winner: 96)
Avg Qrtly EPS: 0% (median winner: 68%)
Industry Group: 9.

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

  • ETFs Impacted by NAFTA Talks Wed, 22 Nov 2017 21:48:09 +0000
    There seems to be some, if not much progress, in NAFTA talks as the fifth round of negotiations close; risks remain.
  • Fitch: Blame Politics For NAFTA Breakdown Tue, 21 Nov 2017 18:57:00 +0000
    NAFTA round five ends today. But NAFTA may end in 2018.
  • How Glencore and TECK’s Capital Allocation Strategies Stack Up Tue, 21 Nov 2017 12:33:47 +0000
    Capital allocation is key for metal and mining companies given the industry’s capital-intensive nature.
  • 5 International ETFs to Get the Best of All Worlds Tue, 14 Nov 2017 16:13:47 +0000
    Although it’s not the most exciting investment, these days, you can’t go wrong with the benchmark exchange-traded fund SPDR S&P 500 ETF Trust (NYSEARCA:SPY). Year-to-date, the trust fund is up nearly 16%. However, given its remarkable rally under ever-declining volume, many investors are seeking alternative opportunities. As such, I believe there’s no better time to consider international ETFs to buy than right now.
  • Oh Canada: Don’t Forget This ETF Up 11% YTD Tue, 31 Oct 2017 16:32:03 +0000
    With U.S. stocks soaring again this year, it is easy for investors to overlook Canada. However, the northern neighbor to the U.S. is home to its own impressive equity market. The iShares MSCI Canada ETF ...
  • Canada ETFs in Focus as Inflation Surges, Retail Sales Fall Tue, 24 Oct 2017 20:12:08 +0000
    Canada's inflation surges on higher gasoline prices; retail sales unexpectedly decline.
  • What Lies Ahead for Canada ETFs? Tue, 03 Oct 2017 20:05:08 +0000
    Canada's GDP growth stalls in July, dimming prospects of an immediate rate rise.
  • Canada ETFs Rise After Unexpected Rate Hike Thu, 07 Sep 2017 22:28:10 +0000
    Canada hikes its key interest rate for the second consecutive time in September, putting the spotlight on ETFs with exposure to the country.
  • Can Canadian ETFs Continue Their Rally? Fri, 01 Sep 2017 20:02:08 +0000
    Canadian GDP rises at the fastest pace in six years on account of better-than-expected household spending.
  • Analysts Are Bullish on Teck Resources in 3Q17 Tue, 29 Aug 2017 18:06:42 +0000
    Of the 19 analysts polled by Thomson Reuters, four rated Teck Resources as a “strong buy,” 13 rated it as a "buy," and two rated it as a “hold.”

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
EWC EPS/Sales Growth EWC vs. Peers



*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Copyright © 1996-2026 Growth Stock Analytics, LLC. All rights reserved.  Site Map | Privacy Policy | Contact Us